Cytospora sp. 24 LY10

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Suppression of CD300A inhibits the growth of diffuse large B-cell lymphoma.
CD300A is a type I transmembrane receptor protein which has shown inhibitory effects on B-cell receptor-mediated signals. In an… (More)
Is this relevant?
2015
2015
Suppression of CD 300 A inhibits the growth of diffuse large B-cell lymphoma
CD300A is a type I transmembrane receptor protein which has shown inhibitory effects on B-cell receptor-mediated signals. In an… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies.
PURPOSE The clinical success of the first-in-class proteasome inhibitor bortezomib (VELCADE) has validated the proteasome as a… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
Highly Cited
2005
Highly Cited
2005
c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells.
Several primary murine and human B lymphomas and cell lines were found to constitutively express high levels of the activated… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?